You are viewing the site in preview mode
Skip to main content
| |
Odds Ratio
| |
|---|
|
Point Estimate
|
95% CI
|
P-value
|
|---|
|
Age
|
1.009
|
(0.997, 1.021)
|
0.1237
|
|
Sex
|
0.816
|
(0.616, 1.080)
|
0.1546
|
|
Target organ damagea
|
0.792
|
(0.568, 1.104)
|
0.1691
|
|
Home sphygmomanometers at baseline
|
0.900
|
(0.665, 1.217)
|
0.4923
|
|
Baseline SBP
|
0.998
|
(0.988, 1.008)
|
0.6615
|
|
Baseline DBP
|
0.986
|
(0.972, 1.000)
|
0.0519
|
|
Dyslipidemiab
|
0.804
|
(0.571, 1.131)
|
0.2105
|
|
FBS ≥100 mg/dL
|
0.601
|
(0.421, 0.857)
|
0.0050
|
|
Central obesity (men ≥90 cm, women ≥80 cm)
|
1.460
|
(1.070, 1.992)
|
0.0171
|
|
Family history of cardiovascular disease (men < 55 years, women < 65 years)
|
1.429
|
(0.584, 3.495)
|
0.4342
|
|
Compliance with HBP (0% vs. over 0%)
|
1.602
|
(1.182, 2.172)
|
0.0024
|
- SBP systolic blood pressure, DBP diastolic blood pressure, FBS fasting blood glucose, BMI body mass index, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol
- aTarget organ damage was defined as a composite of 1) stroke, transient ischemic attack, or vascular dementia; 2) left ventricular hypertrophy, angina, myocardiac infarction, or heart failure; 3) albuminuria (albumin level > 30 mg/g) or chronic kidney disease (eGFR < 60 mL/min/1.73 m2); 4) peripheral vascular disease (ankle-brachial index < 0.9), pulse wave velocity > 10 m/sec, intimal thickness of the carotid artery > 1.0 mm or large artery disease; and 5) stage 3 or 4 hypertensive retinopathy
- bDyslipidemia was defined as total cholesterol level ≥ 230 mg/dL, LDL-C level ≥ 150 mg/dL, HDL-C level < 40 mg/dL, or triglyceride ≥200 mg/dL
